NCT01826045View on ClinicalTrials.gov

Efficacy and Safety Study of PGA (Poly-gamma Glutamic Acid) for Cervical Intraepithelial Neoplasia

PHASE2CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

December 31, 2015

Study Completion Date

January 31, 2016

Conditions
Cervical Intraepithelial Neoplasia
Interventions
DRUG

Poly-gamma Glutamic Acid

DRUG

Placebo

Trial Locations (7)

152-703

Korea University Guro Hospital, Seoul

Korea University Guro Hospital, Seoul

700-712

The Dongsan Medical Center of Keimyung Hospital, Daegu

100-380

Kwandong University College of Medicine Cheil Hospital, Seoul

135-913

CHA Gangnam Hospital, Seoul

137-701

The Catholic University, Korea Seoul St Mary's Hospital, Seoul

157-723

MiZMedi Hospital, Seoul

Sponsors
All Listed Sponsors
lead

BioLeaders Corporation

INDUSTRY

NCT01826045 - Efficacy and Safety Study of PGA (Poly-gamma Glutamic Acid) for Cervical Intraepithelial Neoplasia | Biotech Hunter | Biotech Hunter